We also evaluated the serum biochemical analysis data from the AD model and found that the BUN and the serum creatinine levels were increased in the AD model and decreased by SAMiRNA-AREG treatment (Fig. 4d,e). The gene discussed is AREG; the disease is Alzheimer disease.